Page 2 successful in a number of diseases, including cancer (1). To the same extent, several 25 studies have described the contribution of parasite-derived EVs to the modulation of the 26 host immune system (2) (3) (4) or the pathological effects on host cells (5) . Tools such as 27 transcriptomics and proteomics, have been particularly useful for identification of the 28 immunomodulatory molecules that parasites package into EVs (6). A better 29 understanding of how parasite EVs are produced and interact with host cells may open 30 new avenues for parasite control, since the selective inhibition of these would prevent the 31 delivery of potent immunomodulators that induce a host immune phenotype that favors 32 parasite survival. 33 It is in this context that we established a definitive characterization of the total 34 secretome of the zoonotic parasite Fasciola hepatica (6), one of the causative agents of 35 the trematode foodborne disease known as Fascioliasis. Whilst primarily regarded as a 36 disease of livestock, it is estimated that F. hepatica infects between 2 and 17 million 37 people worldwide, with a further 180 million living at risk of infection (7). Resistance to 38 triclabendazole, the frontline chemical treatment against Fasciola, is rapidly spreading 39 and highlights the need for novel control strategies against the parasite (8).
41

Characterization of the EVs released by Fasciola hepatica 42
EVs released by the parasite during in vitro culture were isolated using ultracentrifugation 43 and ultrafiltration and subsequently analyzed by transmission electron microscopy (TEM) 44 and mass spectrometry. One of the pivotal findings was that Fasciola secretes at least two 45 sub-populations of EVs of varying size that bear different cargo molecules and may be 46 released from distinct sites within the parasite. TEM revealed that the larger EVs are released from the specialized cells that line the parasite gastrodermus and are specifically Page 3 enriched in the zymogen of the 37 kDa cathepsin L peptidase, which mainly performs a 49 digestive function (9). Proteomics and transcriptomics data provided insight into 50 molecular origin of the smaller exosome-like EV population. Whilst a previous exosome 51 characterization study described only the total vesicular content (10), we wanted to obtain 52 a more detailed picture of the vesicle architecture. Thus, we performed a differential 53 extraction of membrane associated proteinsmore likely to participate in interactions 54 with host cellsand those packaged as cargoenvisaged to be delivered into host cells.
55
Mass spectrometry analysis revealed a significant number of proteins belonging to the 56 ESCRT pathway of EV biogenesis and vesicular transport. Together with the abundance 57 of shared tegumental proteins (11), these results suggested that at least some EVs from 58 Fasciola originate from multivesicular bodies within the tegumental syncytium before 59 being shed from the apical plasma membrane. Furthermore, transcriptomics analysis 60 indicated that whilst the molecular "machinery" required for EV biogenesis is Although this study provided insight into the mechanisms that helminth parasites 69 use to produce EVs, it raised a considerable number of questions that need to be addressed 70 before designing a rational therapeutic approach for this or other helminth parasites 71 (reviewed by 12). Our proteomics data largely supports an ESCRT-dependent origin for Page 4 the exosome-like EVs released by F. hepatica (Table 1) . However, further research is 73 needed to determine the specific roles of individual pathway members during exosome 74 biogenesis in liver flukee.g. by RNAi mediated gene silencing, which is functional in 75 this parasite (13). Additionally, before members from these pathways can be selected as Table1) could indicate that F. hepatica uses hybrid routes for EV release as have been 81 described in some mammalian cell types (14). However, this may also be due to the 82 heterogeneity of vesicle populations in the isolated EVs. The lack of specific markers to 83 distinguish EV sup-populations is a common issue in the field (15) and therefore, to 84 establish a broader set of markers would help to discriminate EV populations and track 85 down their site(s) of production and release from the parasite. We found that the zymogen 86 of cathepsin L, specifically enriched in the larger EVs released by the parasite, constitutes 87 a potential marker for this type of vesicle. Our differential extraction approach, which 88 separated membrane-associated proteins from those packaged into the lumen of exosome-89 like vesicles, helped to identify exosomal markers common to many species as well as 90 potential parasite-specific molecules, such as tetraspanins. 
